Connect with us

National

OPCM: “It is a historic landmark in Portugal and Europe”

Published

em

Listen to this article
Photo: Laura Ramos | cannareporter

Approval of the first cannabis-based product or substance in Portugal, dried flowers with 18% THC, come to solve the problems of Portuguese patients who use medical cannabis? Cannareporter contacted Portuguese associations in the field of cannabis, the OPCM – Portuguese Observatory of Medicinal Cannabis and the Cannativa – Cannabis Studies Association. THEonly the OPCM responded, through a letter sent by its president, Carla Dias.

What does this new product on the market represent for the OPCM?
From the OPCM's point of view, the fact that the National Authority for Medicines and Health Products (Infarmed) has approved the first substance based on the cannabis plant for medicinal purposes is a historic milestone in Portugal and in Europe. It is the first of many important steps towards the implementation of law n.2 33/2018, of July 18, on Medicinal Cannabis.

What will be the selling price to the public which, from the perspective of the OPCM, is the most affordable and suitable for this type of product?
From the perspective of the OPCM, the price charged must comply with the law. The pricing regime for preparations or substances based on the cannabis plant for medicinal purposes is regulated in Ordinance No. practice, approved by Infarmed, available on the Infomed website (infarmed.pt)

What other products do you expect to see approved in Portugal?
The preparations and substances based on the cannabis plant that benefit the 7 indications
therapies listed by Infarmed should be the priority at the moment. The submissions of the ACMs are the sole responsibility and will of the companies already licensed. The licensed companies that are able to submit them have certainly carried out their market studies in order to understand the needs of patients in Portugal.

How many patients does the OPCM estimate could benefit from it?
The company that obtained the approval of the first ACM is certainly the holder of this information, which is the result of a market study, which is fundamental in this process. In any case, evaluating the therapeutic indications of this first product with approved ACM and the percentages of patients who do not have their pathology controlled by conventional medication, a number can be arrived at.

How many patients are currently benefiting from cannabis in Portugal and what main difficulties face?
Patients who benefit from cannabis??? Patients so far have not benefited from Medicinal Cannabis as provided for in law n.2 33/2018, of July 18, but they will be able to do so from this moment on, as the greatest difficulty was related to access. The OPCM management is aware that this is certainly the first ACM of others, which will be approved soon and will allow other patients with other pathologies to benefit from them.

What initiatives is the OPCM developing to disseminate these therapies among health professionals and what kind of support is it providing to patients in our country?
According to the statutes, the OPCM “may develop all the actions it deems necessary or convenient for the pursuit of its purpose, always in strict respect for the legislation in force.” In this way, access to therapy provided for by law by patients who need it, which now begins with the first ACM, is the result of a close collaboration between the OPCM and governmental, private and associative entities.

 

________________________________________________________________________________________

 

If you like CannaReporter, please consider supporting independent journalism by making a donation on our Patreon account.

From just €3/month!

________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]
Click here to comment

Leave a comment

Your email address will not be published. Required fields are marked *

Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Events1 hours ago

EVO NXT: Next Generation Products Festival returns to Malaga and Cannabis will be in the spotlight

The 2nd edition of the Business Festival for Next Generation Products, EVO NXT, returns to Malaga this...

International7 days ago

It's official: Germany is the third country in Europe to legalize the recreational use of cannabis

The Bundesrat approved today, Friday, the bill to regulate the use of cannabis for recreational purposes in the country....

BusinessCann1 weeks ago

Germany: Cannabis legalization on the brink? Bundesrat votes on bill tomorrow

Most media outlets announced the legalization of cannabis in Germany as a fait accompli, but...

National1 weeks ago

Portugal: Medicinal cannabis on Madeira Island with autonomous licensing process from the mainland

The Autonomous Region of Madeira is taking over the licensing of activities related to medicinal cannabis in the archipelago, in accordance...

International1 weeks ago

Norway: Activists send 200g of cannabis to the Prime Minister and other politicians by post

Norwegian activists from the Alliance for Human Rights-Oriented Drug Policy (AROD) sent 10 letters with 200...

Events1 weeks ago

Spain: Exponential growth of Spannabis dictates expansion to Bilbao in September

The 20th edition of Spannabis 2024, one of the oldest and largest cannabis fairs in the world, ended yesterday with...

International1 weeks ago

Morocco enters the cannabis race with the first legal cannabis harvest

The year 2023 will go down in Morocco's history as the year in which the first legal harvest of...

Hemp2 weeks ago

USA: USDA announces investment of 10 million in hemp research

The United States Department of Agriculture (USDA) recently released the “Hemp Research Needs Map” and announced a...

Interviews2 weeks ago

Jacqueline Poitras: “Doctors are painfully ignorant when it comes to cannabinoids and their effects on the human body”

Founder of 'MAMAKA- Mothers for Cannabis', an association for medical cannabis patients in Greece, Jacqueline Poitras has been a...

International2 weeks ago

Understanding the UN System & Our Role at CND67 - Midterm Review

The United Nations, in Vienna, hosts annual sessions of the Commission on Narcotic Drugs (CND). These sessions provide opportunities for organizations without...